Medical Marijuana Inc (OTCMKTS:MJNA) is an MMJ play that we turned cold on back in March. The company has well-known potential and an incredibly active investor relations orientation, but ultimately is mysteriously reluctant to open its financial results to any sort of standard levels of transparency or scrutiny despite having a market cap over a quarter of a billion dollars. In any case, the stock has been a big trading favorite, but has acted relatively heavy in recent months, and closed last week with a breach of key support. The stock now faces a test of the dime support level as start a new, holiday-shortened trading week.
The company’s most recent press release notes that its subsidiary Kannaway LLC, “the first hemp lifestyle network to offer phyto-cannabinoid botanical products,” is adding a new option for vaping cannabidiol (CBD) with a new vaporizer cartridge loaded with 100 mg of pure CBD